德龙激光(688170) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥99,165,075.14, a decrease of 14.26% compared to ¥115,657,779.36 in the same period last year[3] - The net profit attributable to shareholders was a loss of ¥16,470,410.56, worsening from a loss of ¥7,263,464.76 year-on-year[3] - The weighted average return on net assets was -1.35%, a decrease of 0.79 percentage points from -0.56%[3] - The basic and diluted earnings per share were both -¥0.16, compared to -¥0.07 in the same period last year[3] - Total operating revenue for Q1 2025 was ¥99,165,075.14, a decrease of 14.3% compared to ¥115,657,779.36 in Q1 2024[15] - Net profit for Q1 2025 was a loss of ¥16,470,410.56, compared to a loss of ¥7,263,464.76 in Q1 2024, representing a deterioration of 126.3%[16] - The total comprehensive loss for Q1 2025 was ¥16,578,062.19, compared to a loss of ¥7,245,782.96 in Q1 2024, reflecting increased financial challenges[16] Cash Flow - The net cash flow from operating activities improved to ¥20,943,240.54, compared to a negative cash flow of ¥34,202,623.08 in the previous year[3] - Cash flow from operating activities for Q1 2025 was ¥20,943,240.54, a significant improvement from a negative cash flow of ¥34,202,623.08 in Q1 2024[18] - Cash flow from investing activities for Q1 2025 was a net outflow of ¥56,764,895.01, compared to a net inflow of ¥28,749,485.60 in Q1 2024[19] - The cash and cash equivalents at the end of Q1 2025 stood at ¥194,579,409.20, down from ¥515,478,331.54 at the end of Q1 2024[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,779,045,772.42, down 3.01% from ¥1,834,177,292.67 at the end of the previous year[4] - As of March 31, 2025, the company's total current assets amounted to approximately CNY 1.35 billion, a decrease of about 4.1% from CNY 1.41 billion on December 31, 2024[11] - The company's total assets were CNY 1.78 billion, down from CNY 1.83 billion, indicating a decrease of approximately 3.0%[12] - Total liabilities decreased to CNY 563.28 million from CNY 601.83 million, a decline of about 6.4%[13] - The equity attributable to shareholders decreased to CNY 1.22 billion from CNY 1.23 billion, a reduction of about 4.7%[13] Research and Development - Research and development expenses totaled ¥30,778,553.04, representing 31.04% of operating revenue, an increase of 5.95 percentage points from 25.09%[4] - Research and development expenses for Q1 2025 were ¥30,778,553.04, up from ¥29,014,771.94 in Q1 2024, indicating a focus on innovation[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 5,681[8] - The largest shareholder held 22.97% of the shares, with a total of 23,745,000 shares[8] - The company has not reported any changes in major shareholders or their participation in margin trading[9] Other Information - The company reported non-recurring gains and losses totaling ¥3,447,263.70 for the period[6] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[10] - The company recorded a foreign exchange loss of ¥107,651.63 in Q1 2025, contrasting with a gain of ¥17,681.80 in Q1 2024[16] - The company reported a significant increase in contract liabilities to CNY 194.07 million from CNY 172.93 million, an increase of approximately 12.1%[12] - Total operating costs for Q1 2025 were ¥122,989,001.71, slightly down from ¥124,415,481.66 in Q1 2024[15] - Accounts receivable decreased to CNY 201.79 million from CNY 269.76 million, a reduction of about 25.2%[11] - Inventory increased to CNY 552.01 million from CNY 506.07 million, reflecting an increase of approximately 9.1%[11]